Figure 2From: Private costs almost equal health care costs when intervening in mild Alzheimer's: a cohort study alongside the DAISY trial Impact of alternative scenarios of the proportion of private copayment by patients with mild Alzheimer's disease and their primary caregivers attending a multifaceted support programme (0.47 in base-case analysis).Back to article page